Neuropsychiatric disorders have become a very prominent public health problem in recent years.
Our company has demonstrated in many examples the reliability of neuropharmacological researches using standard animal behavioral testing methods, including drug screening and safety assessment. We are committed to providing real and valuable feedback on the results of our clients' preclinical drug research projects.
Why Should I Screening and Assessment of Neuropsychiatric Drugs
- With the increasing mental pressure of the public, the incidence of mental illness has gradually increased and has developed into a global problem. The social burden of mental illness has far surpassed that of cardiovascular, cerebrovascular, and oncological diseases, imposing a huge economic and medical burden on society.
- Psychiatric and neurological disorders are usually characterized by multiple episodes and high recurrence rates, requiring regular treatment and long-term medication. Pharmacotherapy has an irreplaceable role in the treatment of related diseases.
- For a long time, the lack of effective treatments for a variety of neurological and psychiatric disorders and the potential side effects of developed drugs have been reported. These factors have made the search for safe and effective novel drugs urgent.